UCHL1 and neoplasm: Growing evidence illustrated that the methylation status and deubiquitinating activity of UCHL1 were associated with patients’ prognosis29–31, and its higher expression in tumor activated the Wnt-β-catenin/TCF pathway to promote cell proliferation, migration and invasion30.